Pharmerica (PMC) Tops Q3 EPS by 3c

Pharmerica (NYSE: PMC) reported Q3 EPS of $0.39, $0.03 better than the analyst estimate of $0.36. Revenue for the quarter came in at $498.8 million versus the consensus estimate of $480.35 million.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
• RCM Technologies (RCMT) Tops Q2 EPS by 17c